Literature DB >> 18336028

Mechanism of reversible alkyne coupling at zirconocene: ancillary ligand effects.

Adam D Miller1, Jennifer L McBee, T Don Tilley.   

Abstract

The mechanism of reversible alkyne coupling at zirconium was investigated by examination of the kinetics of zirconacyclopentadiene cleavage to produce free alkynes. The zirconacyclopentadiene rings studied possess trimethylsilyl substituents in the alpha-positions, and the ancillary Cp2, Me2C(eta(5)-C5H4)2, and CpCp* (Cp* = eta(5)-C5Me5) bis(cyclopentadienyl) ligand sets were employed. Fragmentation of the zirconacyclopentadiene ring in Cp2Zr[2,5-(Me3Si)2-3,4-Ph2C4] with PMe3, to produce Cp2Zr(eta(2)-PhC[triple bond]CSiMe3)(PMe3) and free PhC[triple bond]CSiMe3, is first-order in initial zirconacycle concentration and zero-order in incoming phosphine (k(obs) = 1.4(2) x 10(-5) s(-1) at 22 degrees C), and the activation parameters determined by an Eyring analysis (DeltaH(double dagger) = 28(2) kcal mol(-1) and DeltaS(double dagger) = 14(4) eu) are consistent with a dissociative mechanism. The analogous reaction of the ansa-bridged complex Me2C(eta(5)-C5H4)2Zr[2,5-(Me3Si)2-3,4-Ph2C4] is 100 times faster than that for the corresponding Cp2 complex, while the corresponding CpCp* complex reacts 20 times slower than the Cp2 derivative. These rates appear to be largely influenced by the steric properties of the ancillary ligands.

Entities:  

Year:  2008        PMID: 18336028     DOI: 10.1021/ja800025u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  Negishi's Reagent Versus Rosenthal's Reagent in the Formation of Zirconacyclopentadienes.

Authors:  Sara Urrego-Riveros; Isabel-Maria Ramirez Y Medina; Daniel Duvinage; Enno Lork; Frank D Sönnichsen; Anne Staubitz
Journal:  Chemistry       Date:  2019-09-04       Impact factor: 5.236

2.  Iron-Catalyzed Vinylsilane Dimerization and Cross-Cycloadditions with 1,3-Dienes: Probing the Origins of Chemo- and Regioselectivity.

Authors:  C Rose Kennedy; Matthew V Joannou; Janelle E Steves; Jordan M Hoyt; Carli B Kovel; Paul J Chirik
Journal:  ACS Catal       Date:  2021-01-13       Impact factor: 13.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.